The Path Forward:

Our Commitment to Action

To our ByHeart families,

We built ByHeart on a promise that every formula-feeding family deserves to feel confident in what they're feeding their baby. This outbreak compromised that promise, and we are determined to prevent this from happening again.

Since the start of the recall, we have cooperated closely with the FDA and worked alongside a team of independent experts to conduct an exhaustive investigation examining every ingredient we source, every process we run, and every surface in our facilities. We needed to understand how a pathogen that was previously not considered a likely hazard in infant formula¹ made its way into our product.

What we have learned has given us pivotal insights to inform our path forward. We have always been proud of our rigorous standards, and now we are making them even stronger, reflecting new knowledge in the science of safety. We are working with the FDA on the safe resumption of infant formula production, and these are the immediate steps we are taking.


Comprehensive Root Cause Investigation & Analysis

The FDA announced that it has concluded its inspection of ByHeart's facilities and has shared that it did not identify any deficiencies in ByHeart’s facilities that could explain the root cause of this outbreak.

The agency shared it will continue its investigation into ingredients, including the powdered milk ingredient produced by a third-party supplier where Clostridium botulinum was identified. 

Our Ongoing Commitment to You

We understand that rebuilding trust will take time and consistent, transparent action. We are committed to providing you with regular updates on our progress across all of these categories.

Sincerely,
The ByHeart Team

Discount code copied to clipboard